Versanis Bio
Versanis Bio is advancing bimagrumab, a human monoclonal antibody to the activin type II receptors that blocks the binding of ligands including activin A and myostatin. Bimagrumab has been studied by Novartis in more than a dozen…
This is the record ChatGPT, Claude and Google read about Versanis Bio. Claiming it controls the source; answers update as assistants re-crawl.
- Founded
- 2021
- Headcount
- 17
- Open roles
- 0
- Last raised
- Series A
Where they work
Capital raised
Roles at Versanis Bio
Employbl doesn’t track Versanis Bio’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →
Hiring team? Claim the profile to keep roles and the careers link accurate
Founders & key people
Companies like Versanis Bio
Picked from companies in the same industries as Versanis Bio, ranked by funding-stage adjacency and hiring activity.
Charlie Health
Bozeman, MT · Seed
Charlie Health's virtual Intensive Outpatient Program is focused on helping teens, young adults, and their families in healing.
Allara
Manhattan Park, NY · Series B
Allara offers a medical provider and a registered dietitian for polycystic ovary syndrome. They provides holistic care, diagnostic testing,…
